The Patterson Perspective

As threats evolve, Oligo Security hires a top product leader to advance its real-time defense paradigm, signaling a major shift in cybersecurity talent.

A $24M Dept. of War grant will accelerate production of Seasats' proven autonomous boats, fueling the US Navy's strategic shift to a hybrid fleet.

As IWCE marks its 50th anniversary, the premier event for mission-critical pros looks to the future of public safety tech, from AI to NG911.

Following bankruptcy, iconic Del Monte Foods is sold for parts. Fresh Del Monte, B&G Foods, and Pacific Coast Producers now own its legendary brands.

LiDAR expert Aeva is diversifying, launching a high-power optical amplifier to solve the energy and data bottlenecks plaguing the world's AI data centers.

DataMesh's new Robotics platform moves beyond static models, offering dynamic, executable digital twins to train embodied AI for complex real-world tasks.

B'laster Holdings names Tad Schimmelpfennig its new CEO, signaling a strategic push to dominate retail shelves and deepen its automotive aftermarket grip.

Eagle Pharmaceuticals divests its unique post-op nausea drug to France's LXO Group, signaling a strategic pivot to oncology and critical care.

Walmart's first Eastvale Supercenter promises jobs and modern retail, but residents and local businesses brace for its impact on traffic and competition.

Gerri Martin-Flickinger, former CTO of Starbucks and CIO of Adobe, is now Board Chair at Renaissance, signaling a major push into AI-driven learning.

In a strategic move, UCL Swift hires industry veteran Steve Harris to lead broadband efforts, tackling both technological innovation and the critical skills gap.

An asset manager's quirky mascot, Sortino the duck, is winning awards by making a serious point about downside risk in today's uncertain markets.

The trading platform adds a third regulatory approval, bolstering its compliance framework and setting the stage for strategic expansion in Africa and Asia.

VisionWave Holdings launches a major joint venture with Israeli partner AIPHEX, integrating AI, quantum tech, and a key financial contract.

With preliminary Q1 revenue of $103.7M, Twist Bioscience beats forecasts, setting a bullish tone ahead of its full earnings report on February 2nd.

With its first MASH drug a success, Madrigal aims to redefine treatment by combining it with a newly licensed Pfizer asset. Is this the future?

The global VR leader continues its rapid Canadian growth, opening a high-tech virtual reality venue in Vaughan amid a booming market for immersive group fun.

Amid soaring costs, firms are ditching transactional rebates for incentives that drive behavior, build relationships, and secure market share.

MiNK Therapeutics and UW–Madison launch a trial for an 'off-the-shelf' cell therapy, aiming to prevent deadly Graft-Versus-Host Disease (GvHD).

Record AI mega-deals redefine healthcare innovation, yet a broader market contraction creates a new divide for startups and traditional medical sectors.